UnitedHealth's 2025 EPS Outlook Amid Rising Medical Costs

Leadership’s Commitment to Reform and Operational Changes

Stephen J. Hemsley, CEO of UnitedHealth Group, opened the earnings call by emphasizing a “tone of change and reform” that reflects a recommitment to the company's mission of helping people live healthier lives and improving the healthcare system for everyone. He highlighted a “real cultural shift” in the company’s relationship with regulators and external stakeholders. Hemsley acknowledged past mistakes, including pricing and operational errors, and stated that these issues are now receiving the attention they deserve. He also outlined extensive management and operational changes aligned with this reform agenda, indicating that further changes across leadership, business units, and governance will continue.

Medical Cost Projections and Adjustments

Timothy John Noel, CEO of UnitedHealthcare Business, provided insights into the company’s updated medical cost outlook for 2025. He noted that the current view reflects an additional $6.5 billion in medical costs compared to the initial outlook. Over half of this increase is attributed to the Medicare portfolio, with the remainder split between commercial and Medicaid businesses. Noel mentioned that the full-year 2025 trend is expected to be approximately 7.5%, up from the previously assumed 5%. He also emphasized that UnitedHealthcare is intensifying its remediation actions and has stepped up its audit, clinical policy, and payment integrity tools.

Performance Challenges in OptumHealth

Patrick Hugh Conway, CEO of Optum Rx, acknowledged that Optum's performance this year has not met expectations. He cited a $6.6 billion shortfall in OptumHealth earnings versus expectations, with $3.6 billion concentrated in value-based care. Conway emphasized that the company is taking swift steps to recapture its historic momentum.

Financial Highlights and Outlook

John F. Rex, President and CFO, shared that UnitedHealth Group reported revenues of nearly $112 billion, a 13% increase over the prior year. However, adjusted earnings per share of $4.08 was below the same period last year. Rex explained that the quarter included about $1.2 billion in discrete items, primarily from unfavorable impacts to ACA exchange offerings and several one-time settlements.

The company’s adjusted earnings outlook for 2025 is “at least $16 per share.” Rex added that revenues will approach $448 billion, representing an 11% growth over 2024. The full-year medical care ratio is expected to be 89.25%, plus or minus 25 basis points, compared to the prior 86.5% midpoint. Hemsley remarked that he expects solid but moderate earnings growth in 2026, with a Medicare Advantage pricing strategy assuming a trend approaching 10%.

Strategic Adjustments and Portfolio Rationalization

UnitedHealthcare plans significant adjustments to benefits and will exit plans serving over 600,000 members, mainly in PPO offerings. OptumHealth expects to cease arrangements for about 200,000 patients largely in fully accountable PPO products.

Q&A Insights and Analyst Concerns

During the Q&A session, analysts raised questions about margin projections, payer pricing, and the sustainability of recovery strategies. Patrick Hugh Conway addressed concerns about OptumHealth margins, stating that adjustments in pricing could provide a tailwind. John F. Rex confirmed that 80% of premium revenues reprice on January 1, with future margin targets expected to expand to 2.5%-3%.

Hemsley expressed confidence in the company’s ability to steadily return to low double-digit EPS growth and advance from there. Timothy John Noel reaffirmed that there is no change to the targeted margin range across UnitedHealthcare.

Sentiment and Management Tone

Analysts maintained a probing and cautious tone, focusing on margin recovery, pricing discipline, and the credibility of new strategic and operational changes. Management reflected humility and urgency, acknowledging past mistakes while expressing confidence in the remediation plan. Hemsley emphasized regaining the intensity, precision, and executional disciplines required for consistent performance.

Risk Factors and Operational Challenges

Management cited the need for a fundamental reorientation in several businesses, including the impact of a generational pullback in Medicare funding and unprecedented medical cost trends. The company faces challenges such as Medicaid and exchange market contraction, lagging state Medicaid rate updates, and execution risks in value-based care turnaround.

Final Takeaway and Future Outlook

UnitedHealth Group’s leadership emphasized a sweeping agenda of reform and operational overhaul after identifying nearly $6.5 billion in additional medical costs and a significant earnings outlook reset for 2025. The company is executing extensive structural, leadership, and process changes, focusing on pricing discipline, cost control, and robust engagement with regulators and stakeholders. UnitedHealth is pursuing margin recovery through aggressive repricing, portfolio rationalization, benefit cuts, and investments in technology and AI, while acknowledging that 2026 will remain a transition year with stronger earnings growth anticipated from 2027 onward.